Product image of Xofigo (Radium Ra 223 Dichloride) supplied by GNH India

Xofigo

Active Ingredient:
Radium Ra 223 Dichloride
Origin:
EU

Xofigo (Radium Ra 223 Dichloride)

Xofigo (Radium Ra 223 Dichloride) is a radiopharmaceutical used for targeted therapy in certain cancers. Administered intravenously, it delivers alpha radiation to bone metastases. Suitable for patients seeking advanced cancer treatment options. Short-term storage guidance may apply.

Manufacturer / TM Owner

Bayer Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Xofigo is primarily used to treat bone metastases in patients with castration-resistant prostate cancer. It targets areas of high bone turnover, delivering localized radiation. This therapy is often considered when other treatments have not been effective. Patients may ask, 'what is Xofigo used for' to understand its role in cancer care.

Side Effects

  • Patients may experience fatigue or nausea after receiving Xofigo. Bone pain relief is a reported effect in some cases. The treatment is designed to slow disease progression rather than provide immediate symptom relief. Individual responses can vary widely.

Precautions & Warnings

  • Xofigo should only be handled by healthcare professionals trained in radiopharmaceuticals. Pregnant individuals or those planning pregnancy should avoid exposure. Close contact with others may need to be limited temporarily after treatment. Always disclose medical history to your provider before use.

Avoid Interactions

  • Limited data exists on drug interactions with Xofigo due to its targeted nature. Concurrent use of other radiopharmaceuticals or chemotherapy may require careful monitoring. Alcohol and certain supplements could affect treatment tolerance. Consult your doctor for personalized guidance.

Frequently Asked Questions

Xofigo is given as an intravenous injection by a healthcare professional. The procedure typically takes a few minutes.

Common side effects include fatigue, nausea, and bone pain. These effects are usually temporary and managed by your care team.

Xofigo is not a cure but may slow disease progression in certain cases. It is used to manage symptoms and improve quality of life.

Pregnant individuals, those planning pregnancy, or patients with severe bone marrow suppression should avoid this therapy.

Xofigo is typically administered in 6 injections, one every 4 weeks. Your doctor will determine the exact schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Radium Ra 223 Dichloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT